Publicacións nas que colabora con Moises Rodríguez Mañero (11)
2024
-
Cost–Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study
Diseases, Vol. 12, Núm. 10
2023
-
Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593
-
Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation
International Journal of Molecular Sciences, Vol. 24, Núm. 18
2022
-
Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors
Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 245-252
-
Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers
Scientific Reports, Vol. 12, Núm. 1
-
The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation
International Journal of Molecular Sciences, Vol. 23, Núm. 19
2019
-
A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population
International Journal of COPD, Vol. 14, pp. 371-380
-
Ablation of atrial fibrillation in patients with Brugada syndrome: A systematic review of the literature
Journal of Arrhythmia, Vol. 35, Núm. 1, pp. 18-24
2018
-
Relevance of Dementia in Atrial Fibrillation Patients within a Specific European Health Care Area
Neuroepidemiology, Vol. 51, Núm. 1-2, pp. 11-18
-
Validating Left Atrial Low Voltage Areas During Atrial Fibrillation and Atrial Flutter Using Multielectrode Automated Electroanatomic Mapping
JACC: Clinical Electrophysiology, Vol. 4, Núm. 12, pp. 1541-1552
2017
-
Clinical profile and outcomes in octogenarians with atrial fibrillation: A community-based study in a specific European health care area
International Journal of Cardiology, Vol. 243, pp. 211-215